JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505071200 on May 10, 2005

J. Biol. Chem., Vol. 280, Issue 29, 27022-27028, July 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/29/27022    most recent
M505071200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Q.
Right arrow Articles by Cao, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Q.
Right arrow Articles by Cao, X.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-{alpha}-positive Breast Cancer Cells*{boxs}

Qingnan Li{ddagger}§, Liyu Wu{ddagger}, Denise K. Oelschlager{ddagger}, Mei Wan{ddagger}, Cecil R. Stockard{ddagger}, William E. Grizzle{ddagger}, Ning Wang{ddagger}, Huaiqing Chen¶, Yi Sun§, and Xu Cao{ddagger}§||

From the {ddagger}Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0019, the §Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China, and the Institute of Biomedical Engineering, West China Center of Medical Sciences, Sichuan University, Chengdu, Sichuan 610041, China

Estrogen is a mitogen in most estrogen receptor-{alpha} (ER{alpha})-positive breast cancers. We have found that Smad4, a common signal transducer in the transforming growth factor-{beta} superfamily, acts as an ER{alpha} transcriptional corepressor. Here, we show that Smad4 induces apoptosis in ER{alpha}-positive MCF-7 breast cancer cells, but not in ER{alpha}-negative MDA-MB-231 cells. Smad4 induced expression of short Bim isoforms (by alternative splicing) and Bax and release of cytochrome c in ER{alpha}-positive cells only, and expression of these apoptotic marker genes was reduced when ER{alpha} small interfering RNA was introduced. Notably, Smad4 was able to induce apoptosis in MDA-231 cells with acquired ER{alpha} expression. Furthermore, Smad4 inhibited ER{alpha}-positive tumor growth by inducing apoptosis in tumor xenografts in nude mice. The sizes of tumors expressing Smad4 were only one-tenth the size of those expressing green fluorescent protein, whereas in ER{alpha}-negative cells, Smad4 did not reduce the tumor size. Notably, Smad4 also promoted short Bim isoform and Bax expression and release of cytochrome c only in ER{alpha}-positive MCF-7 tumor xenografts. Bim was sufficient for induction of apoptosis, and the short form was the most potent inducer. Our results demonstrate that Smad4 induces apoptosis by regulating Bim splicing as an initial intrinsic signal in ER{alpha}-positive cells. Smad4-induced apoptosis in ER{alpha}-positive breast cancer cells may explain the invasive nature of ER{alpha}-negative breast tumors, thereby providing a potential target for breast cancer intervention.


Received for publication, May 9, 2005

* This work was supported by Department of Defense Grant BC010975 (to X. C.) and National Institutes of Health Grant DK60913 (to X. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. 1S and 2S.

|| To whom correspondence should be addressed: Dept. of Pathology, University of Alabama at Birmingham, 1670 University Blvd., VH G003, Birmingham, AL 35294-0019. Tel.: 205-934-0162; Fax: 205-934-1775; E-mail: cao{at}path.uab.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
J. E Burdette and T. K Woodruff
Activin and estrogen crosstalk regulates transcription in human breast cancer cells
Endocr. Relat. Cancer, September 1, 2007; 14(3): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al.
Estrogen Receptors: How Do They Signal and What Are Their Targets
Physiol Rev, July 1, 2007; 87(3): 905 - 931.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.